Blood cancer patients reveal hidden financial toll of treatment
NCT ID NCT05212233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study surveyed 218 adults with chronic lymphocytic leukemia or multiple myeloma to measure how often treatment causes financial difficulty. Patients answered questions about money worries over the past year. The goal was to identify common financial burdens and what resources are available to help.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Albert Einstein College of Medicine
The Bronx, New York, 10467, United States
-
LSU Health Baton Rouge-North Clinic
Baton Rouge, Louisiana, 70805, United States
-
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler
Savannah, Georgia, 31405, United States
-
Mayo Clinic Cancer Center
Phoenix, Arizona, 85054, United States
-
Thomas Jefferson University Hospital
Philadelphia, Pennsylvania, 19107, United States
-
UNC Medical Center
Chapel Hill, North Carolina, 27599, United States
-
University Of Alabama At Birmingham
Birmingham, Alabama, 25448, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could muscle loss predict blood cancer outcomes?
- Can a Triple-Action antibody deepen remissions in myeloma?
- Can a Low-Dose antifungal shield vulnerable patients from deadly fungal infections?
- Can a gentler chemo prep make stem cell transplants safer for blood cancer patients?
- Talking about the end: could guided conversations reduce futile cancer treatments?
- A guided path back to work after blood cancer: a trial tests the impact